Nectar Lifesciences Limited — Proxy Solicitation & Information Statement 2025

Jul 23, 2025

Nectar Lifesciences Ltd.

==> picture [93 x 53] intentionally omitted <==

Ref. No.: NLL/CS/2025- 526

July 23, 2025

To,

1. National Stock Exchange of India Limited Listing Department, Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai 400 051 Symbol: NECLIFE

2. BSE Limited Corporate Relationship Department, P J Towers, Dalal Street, Mumbai 400 001

Scrip Code: 532649

Sub: Corrigendum to the Notice of 2025-26/01[st] Extraordinary General Meeting (“EGM”).

Dear Sir/Madam,

We wish to inform you that the Board of Directors, in their meeting held on July 23, 2025, have interalia, decided and approved the elaboration of mode of rewarding of shareholders as specified in the explanatory statement of item no. 3 of Notice of EGM i.e. in the form of special dividends and / or Buyback of Equity Shares by the Company or mix of both.

The Board has also approved the corrigendum to this effect in the explanatory statement to item no. 3 of Notice of EGM. A copy of such corrigendum being issued to the shareholders is attached herewith.

The Board meeting commenced at 11:30 A.M. and concluded at 12:10 P.M.

This is for your information and records.

Thanking you, Yours faithfully, For Nectar Lifesciences Limited

Sanjaymohan Digitally signed by Sanjaymohan Singh Rawat Date: 2025.07.23 12:24:00 Singh Rawat +05'30' (Sanjaymohan Singh Rawat) Company Secretary & Compliance Officer

Corporate Office: S.C.O. 38-39, Sector 9-D, Chandigarh-160 009, INDIA Telephone: +91-0172-5047915 Registered Office & Works: Village Saidpura, Tehsil Dera Bassi, District Sahibzada Ajit Singh Nagar, Punjab-140507, INDIA Telephone: +91-01762-534 001, +91-01762-534 002, Fax: +91-01762-531 833

Website: www.neclife.com, E-mail: sales@neclife.com, CIN: L24232PB1995PLC016664

==> picture [76 x 42] intentionally omitted <==

Nectar Lifesciences Limited

(Corporate Identification Number: L24232PB1995PLC016664) Registered Office: Village Saidpura, Tehsil Derabassi, Distt. S.A.S. Nagar (Mohali) Punjab - 140507 Email: cs@neclife.com, Website: www.neclife.com, Phone: +91-01762-534001 Fax: +91-01762- 531833

CORRIGENDUM TO THE 2025-26/01[ST] EXTRA ORDINARY GENERAL MEETING

The Nectar Lifesciences Limited (“Company”) has issued a notice dated July 07, 2025 (“Notice of EGM”) for convening the 2025-26/01[st] Extraordinary General Meeting (“EGM”) of the members of the Company which is scheduled to be held on Monday, August 04, 2025 at 10.00 A.M. (IST) at the registered office of the Company situated at Village Saidpura, Tehsil Derabassi, District S.A.S. Nagar (Mohali) 140 507, Punjab. The Notice of the EGM has been dispatched to the shareholders of the Company, whose names appear in the Register of Members/ list of Beneficial Owners on July 04, 2025, in due compliance with the provisions of the Companies Act, 2013 read with the relevant rules made thereunder and LODR Regulations.

The Board of Directors in their meeting dated July 23, 2025, have approved the mode of rewarding shareholders of the Company in the form of special dividends and/ or Buyback of Equity Shares by the Company or mix of both and also instructed to inform shareholders by giving this Corrigendum. In order to update the above disclosures in the Notice of EGM, this corrigendum ("this corrigendum") is being issued to amend the Item No. 3 of the Explanatory Statement as under:

The following existing 4th paragraph in Item No. 3 of the Explanatory Statement:

“The object and commercial rationale for the Proposed Transaction is to utilise the sale proceeds for strategic purposes, including repayment of existing debt, investment in new projects, rewarding shareholders , and general corporate purposes, as deemed fit by the Board or its committee, in accordance with applicable law.”

shall be replaced with following Revised Paragraph :

“The object and commercial rationale for the Proposed Transaction is to utilise the sale proceeds for strategic purposes, including repayment of existing debt, investment in new projects, rewarding shareholders in the form of special dividends and / or Buyback of Equity Shares by the Company or mix of both and general corporate purposes, as deemed fit by the Board or its committee, in accordance with applicable law.”

The Notice of EGM Notice is updated by way of this corrigendum in order to update the above-stated disclosures. This Corrigendum to the EGM Notice shall form an integral part of the Notice of EGM, which has already been circulated to the Shareholders of the Company, and on and from the date hereof, the Notice of EGM shall always be read in conjunction with this Corrigendum. Except for the change as mentioned above, all contents of the Notice of EGM remain the same. This corrigendum is also be made available on website of both the stock exchanges i.e. BSE and NSE and on the website of the Company (www.neclife.com). Capitalized words and expressions used but not defined herein shall have the same meaning as assigned to them in the Notice of EGM.

In case member have any queries regarding log into E-voting or Documents/Email Registrations they may send an email to cs@neclife.com.

By order of the Board of Directors of Nectar Lifesciences Limited

Date: July 23, 2025 Place: Chandigarh (Sanjiv Goyal) Chairman & Managing Director DIN: 00002841

1